0
Home
News
Directory
E-newsletter
Magazine
Events
Data
AgReport
Subscribe
Kan biosys – Strategically poised for growth closes first round of equity investment
Apr. 4, 2018
Kan biosys Pvt. Ltd
IndiaFollow
IndiaThe completion of this round will further support the momentum of Kan biosys over last 3 years, with expansion in more states in India and also for its export push in other countries. Funds raised will be used for fortifying its unique R and D - SMART BIOPLATFORM and upgrading the production and marketing capacities.
Kan biosys was promoted by Sandeepa Kanitkar, an industrial microbiologist turned entrepreneur with a rich experience of over two decades. After closure of the first round of investment, Sandeepa Kanitkar said, “We have a culture repository of more than 5000 microbes and innovative SMART Bioplatform – SMBF to formulate microbes into marketable products. Being pioneers in this field it enables us to consistently be ahead of our competitors as our tried and tested SMBF reduces time to market considerably. Starting from first patent in Liquid biofertilizers in 1993 which enabled us not only to increase the shelf life and shelf-stability but also work on MCLF technique or more popularly known today as “Consortia approach”. 16 products have been registered in India and are certified for organic [ NOP- USA, NPOP -India, BFA- Australia and EU – Europe] and conventional residue free farming in 5 countries. Our products also have OMRI -USA listing.
Kan biosys is an agricultural biologics company engaged in discovery, development, production and commercializing products containing beneficial microbes used to help farmers to improve yields of crops sustainably, reduce residues, grow healthy food and make farming economical. R and D is harnessed through SMART BIOPLATFORM. This platform churns out microbial technologies/ products in record time which help to manage nutrients, pests and soil health. Kan biosys has a state of art fermentation facility in India at Pune near Mumbai in India to produce more than 1 million litres of liquid inoculants and 1000 tons of powder and granule based microbial inoculants.
Kan biosys offers advanced microbial technology from seed to harvest. An array of selective and efficient strains of microbes are formulated, using award winning and patented processes into hi-tech products. Ms Kanitkar says, “Kan biosys is the best agricultural microbial company in India and would like to make a mark globally. Future belongs to sustainable agriculture and we believe Kan biosys has a significant role in realizing the full potential and be the largest player in this field globally”.
Kan biosys continues to grow with its momentum closing the year 2017-18 with revenue of USD 3.5 mn which is 43% growth from 2016-17. The company expanded its distribution strength in 10 states in India and also doubled its export sales. The company plans to expand its presence across India in the current year. The company is also planning to increase its exports to US, Australia and Europe through some strategic alliances and hiring some key people in sales team. The company doubled its production capacity during the year and has further plans of capacity augmentation in the coming year.
The company recently got support from Technology Development Board (TDB) of Government of India for its ambitious project of rice straw utilization in the Soil Carbon Project. TDB extended a soft loan for this project which is aimed at stopping the rice straw burning by rice farmers in Punjab and Haryana and improving the deteriorating soil quality in these states, thereby helping the environment of the region and also helping in sustainable agriculture in the states. Ms Kanitkar says that the Soil Carbon Project has a wide application of benefitting almost entire North India during the rice harvesting months of October and November on over 4.14m ha of rice cultivated just in 2 states in the Monsoon or Kharif crop. The infamous October smog over the capital now has a microbial solution!”
Source: Kan biosys
More from AgroNews
Change
Hot TopicSubscribe
| Subscribe Email: | * | |
| Name: | ||
| Mobile Number: | ||
Comment
0/1200
NEWSLETTER